• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用世界卫生组织 A、C、W、Y 和 X 多糖型国际标准测定脑膜炎球菌多糖结合疫苗的糖含量。

Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides.

机构信息

Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Hertfordshire, EN6 3QG, UK.

Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, Potters Bar, Hertfordshire, EN6 3QG, UK.

出版信息

Biologicals. 2021 Apr;70:53-58. doi: 10.1016/j.biologicals.2021.01.001. Epub 2021 Jan 29.

DOI:10.1016/j.biologicals.2021.01.001
PMID:33518432
Abstract

Potency of meningococcal polysaccharide-protein conjugate vaccines relies on the polysaccharide content to prevent meningitis. NIBSC, as the official national control laboratory in UK, analysed ten different mono- and multi-meningococcal conjugate vaccines, using established International Standards for meningococcal serogroups A, C, W, Y and X, by resorcinol or HPAEC-PAD assay. Most saccharide contents were within ±20% of their claimed content for licensure with taking different O-acetylation levels into consideration, with only MenC content in two vaccines below (by 60% and 54%) the labelled value, however, previous study showed different dosage was not necessarily correlated to the immunogenicity of those vaccines. This study demonstrated the use of International Standards to quantify saccharide content in polysaccharide-based vaccines with different percentage of O-acetylation. These International Standards are suitable to serve as either quantitative standard or calibrator of in-house standards, with supplied stability data.

摘要

脑膜炎球菌多糖蛋白结合疫苗的效力依赖于多糖含量以预防脑膜炎。NIBSC 作为英国的官方国家对照实验室,使用已建立的国际标准品(脑膜炎奈瑟菌血清 A、C、W、Y 和 X),通过间苯二酚或 HPAEC-PAD 分析了十种不同的单价和多价脑膜炎球菌结合疫苗。考虑到不同的 O-乙酰化水平,大多数糖含量与其许可的声称含量在±20%范围内,只有两种疫苗中的 MenC 含量低于(分别为 60%和 54%)标签值,但之前的研究表明,不同的剂量不一定与这些疫苗的免疫原性相关。本研究证明了使用国际标准品来定量多糖基疫苗中的多糖含量,这些疫苗具有不同的 O-乙酰化百分比。这些国际标准品适合作为定量标准或内部标准的校准品,提供稳定性数据。

相似文献

1
Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides.使用世界卫生组织 A、C、W、Y 和 X 多糖型国际标准测定脑膜炎球菌多糖结合疫苗的糖含量。
Biologicals. 2021 Apr;70:53-58. doi: 10.1016/j.biologicals.2021.01.001. Epub 2021 Jan 29.
2
Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.多价多糖结合型脑膜炎球菌疫苗中血清群的定量:水解条件和色谱方法的优化。
Vaccine. 2013 Aug 12;31(36):3702-11. doi: 10.1016/j.vaccine.2013.05.098. Epub 2013 Jun 10.
3
Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM, DT and TT glycoconjugate vaccines.A、C、W、Y群脑膜炎球菌-CRM、DT和TT糖共轭疫苗的质量、免疫原性及稳定性
Vaccine. 2017 Jun 16;35(28):3598-3606. doi: 10.1016/j.vaccine.2017.03.066. Epub 2017 Apr 10.
4
Evaluation of candidate international standards for meningococcal serogroups A and X polysaccharide.A群和X群脑膜炎球菌多糖候选国际标准的评估
Biologicals. 2017 May;47:33-45. doi: 10.1016/j.biologicals.2017.03.001. Epub 2017 Apr 5.
5
Glycoconjugate content quantification to assess vaccine potency: A simplified approach.糖缀合物含量定量评估疫苗效力:一种简化方法。
Biologicals. 2022 Apr;76:10-14. doi: 10.1016/j.biologicals.2022.02.004. Epub 2022 Mar 6.
6
Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.一剂次脑膜炎球菌(A、C、W和Y群)多糖白喉类毒素结合疫苗的安全性和免疫原性
Vaccine. 2016 Oct 17;34(44):5273-5278. doi: 10.1016/j.vaccine.2016.09.003. Epub 2016 Sep 15.
7
A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.一项评估幼儿使用不同配方的四价脑膜炎球菌(A、C、Y 和 W-135)结合破伤风蛋白疫苗的安全性和免疫原性的随机试验。
Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34.
8
Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA.采用夹心 ELISA 法定量新型五价脑膜炎球菌多糖结合疫苗(Men A-TT、Men C-CRM、Men Y-CRM、Men W-CRM、Men X-TT)。
Vaccine. 2020 Nov 17;38(49):7815-7824. doi: 10.1016/j.vaccine.2020.10.017. Epub 2020 Oct 24.
9
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15-25 years.15至25岁青少年中A、C、W-135和Y型破伤风类毒素结合型脑膜炎球菌候选疫苗(MenACWY-TT)制剂的免疫原性、反应原性及持久性
Vaccine. 2009 Jan 1;27(1):161-8. doi: 10.1016/j.vaccine.2008.08.075. Epub 2008 Oct 1.
10
Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.A+W 脑膜炎球菌荚膜多糖体外膜囊泡疫苗的临床前免疫原性与功能活性研究及其与现有脑膜炎球菌结合疫苗与多糖体疫苗之比较。
Vaccine. 2013 Dec 9;31(51):6097-106. doi: 10.1016/j.vaccine.2013.09.044. Epub 2013 Oct 10.

引用本文的文献

1
Further Insights into the Measurement of Free Polysaccharide in Meningococcal Conjugate Vaccines.对脑膜炎球菌结合疫苗中游离多糖测量的进一步见解。
Vaccines (Basel). 2025 Feb 9;13(2):167. doi: 10.3390/vaccines13020167.
2
Evaluation of Critical Quality Attributes of a Pentavalent (A, C, Y, W, X) Meningococcal Conjugate Vaccine for Global Use.用于全球使用的五价(A、C、Y、W、X)脑膜炎球菌结合疫苗关键质量属性的评估
Pathogens. 2021 Jul 23;10(8):928. doi: 10.3390/pathogens10080928.